Condition: Malignant Testicular Germ Cell Tumor · Sponsor: University of Southern California
This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
This description comes directly from the study's public registry record.
Ileana Aldana · 323-865-0702 · Ileana.Aldana@med.usc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham Cancer Center | Birmingham, Alabama, United States | Recruiting |
| Loma Linda University Medical Center | Loma Linda, California, United States | Recruiting |
| Los Angeles County-USC Medical Center | Los Angeles, California, United States | Recruiting |
| USC / Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Rutgers Cancer Institute of New Jersey / Jack and Sheryl Morris Cancer Center | New Brunswick, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06060873